View of Design, Synthesis, and Evaluation of Novel 7-(2-hydrazineyl-2-oxoethoxy)-5-hydroxyflavone Derivatives as CDK9 Inhibitors for Targeted Breast Cancer Therapy

Return to Article Details Design, Synthesis, and Evaluation of Novel 7-(2-hydrazineyl-2-oxoethoxy)-5-hydroxyflavone Derivatives as CDK9 Inhibitors for Targeted Breast Cancer Therapy Download Download PDF